Xu-Dong Wang
8PUBLICATIONS
27CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (8)
Sort by Publication Date:
|Sep 26, 2025
Chemoproteomic Profiling of Reactive Cysteines in Response to Oxidative Stress Induced by 6-Hydroxydopamine.Rayan Murtada, Chiho Kim, Xu-Dong Wang
|Jun 27, 2024
Diagnostic and Prognostic Markers for Pancreatitis and Pancreatic Ductal Adenocarcinoma.Havish S Kantheti, Michael A Hale, Shreoshi Pal Choudhuri
|Jan 19, 2024
Induced degradation of lineage-specific oncoproteins drives the therapeutic vulnerability of small cell lung cancer to PARP inhibitors.Chiho Kim, Xu-Dong Wang, Zhengshuai Liu
|Oct 25, 2023
Nimbolide targets RNF114 to induce the trapping of PARP1 and synthetic lethality in BRCA-mutated cancer.Peng Li, Yuanli Zhen, Chiho Kim
|Aug 27, 2020
PARP1 inhibitors trigger innate immunity via PARP1 trapping-induced DNA damage response.Chiho Kim, Xu-Dong Wang, Yonghao Yu
|May 16, 2020
The p38-interacting protein p38IP suppresses TCR and LPS signaling by targeting TAK1.Xu-Dong Wang, Chen-Si Zhao, Qi-Long Wang
Pageof 2
Frequent Collaborators
3 joint publications
Chiho Kim
3 joint publications
Yonghao Yu
2 joint publications
Peng Li
2 joint publications
Zhengshuai Liu
1 joint publications
Trisha K Savage
1 joint publications
Jane E Johnson
1 joint publications
Chen-Si Zhao
1 joint publications
Zhi-Long Chen
1 joint publications
Yingqiu Li
1 joint publications
Tian Qin
